Market Cap 11.11M
Revenue (ttm) 620,000.00
Net Income (ttm) -8.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,404.84%
Debt to Equity Ratio 0.00
Volume 59,100
Avg Vol 183,644
Day's Range N/A - N/A
Shares Out 5.17M
Stochastic %K 10%
Beta 2.41
Analysts Strong Buy
Price Target N/A

Latest News on MGRX

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 21, 2024, 5:10 PM EDT - 5 months ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly


Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 18, 2024, 4:05 PM EDT - 9 months ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access